Intended for healthcare professionals

Research News

Pioglitazone seems safe and effective for patients with fatty liver disease and diabetes

BMJ 2016; 353 doi: https://doi.org/10.1136/bmj.i3435 (Published 21 June 2016) Cite this as: BMJ 2016;353:i3435